National Healthcare PE ratio NHC

Share price divided by earnings per share over the last twelve months, since 2012.

Today, Oct 23, 2026: 26.5×
10-year median: 21.4×
Against its 10-year history: 71st; percentile: 0 is its lowest day, 100 its highest
10-year range: 11.7× to 52.8×
Peer median: 25.6×

National Healthcare's PE ratio is 26.5× as of Oct 23, 2026: a share price of $236.01 against $8.89 of earnings per share over the last twelve months.

That is above its ten-year median of 21.4×, higher than on 71% of days in the last ten years.

Over that time it ranged from 11.7× in Feb 2025 to 52.8× in Jun 2020.

The median for 10 hospital and care facility stocks of a similar size is 25.6×.

PE ratio over time

median 21.4×

The dashed line is the 10-year median and the shaded band the middle half of its days.

Open the interactive chart, with overlays and comparisons

Year by year

Year	End of year	Low	High
2026 so far	26.5×	20.0×	29.0×
2025	21.4×	11.7×	21.9×
2024	13.7×	13.7×	33.6×
2023	31.8×	24.4×	51.0×
2022	28.9×	28.0×	35.1×
2021	13.3×	11.8×	40.2×
2020	36.7×	14.3×	52.8×
2019	17.9×	14.2×	21.6×
2018	19.1×	16.0×	27.1×
2017	19.0×	19.0×	22.4×
2016	22.2×	18.5×	22.8×
2015	20.0×	19.2×	21.8×
2014	19.9×	13.3×	19.9×
2013	14.4×	12.9×	14.9×
2012	13.7×	12.4×	14.6×

Against its peers

Companies in Medical - Care Facilities nearest National Healthcare's size, closest first, today.

Company	PE ratio
NHCNational Healthcare	26.5×
OPCHOption Care Health	23.5×
AVAHAveanna Healthcare	10.9×
PRVAPrivia Health	107×
LFSTLifeStance Health	99.5×
CONConcentra Group Holdings Parent	25.5×
SHCSotera Health	31.8×
MDPediatrix Medical	14.0×
ADUSAddus HomeCare	21.4×
PGNYProgyny	31.5×
CHEChemed	25.8×
Peer median	25.6×

Where National Healthcare ranks

What the PE ratio tells you

Share price divided by earnings per share over the last twelve months. It is the price tag on a dollar of profit: 20× means you pay $20 for $1 of yearly earnings.

Blank while earnings are negative. A very low PE can mean the market expects profits to fall, so read it with growth and the company's own history.

More on National Healthcare

Valuation data, not investment advice. Prices as of Oct 23, 2026. Reported figures come from the company's filings with the SEC.